Kangwanyotsak, K. and Tongyoo, S. 2024. Composite adverse events compared early versus conventional cessation of hydrocortisone in patients with septic shock: Randomized-controlled trial (The CESSHYDRO study): Cessation of hydrocortisone in septic shock patient. Clinical Critical Care. 32, 1 (Mar. 2024), e240003. DOI:https://doi.org/10.54205/ccc.v32.266229.